At the very beginning of this year, I wrote an HHCN+ Report on the home health public market and how it sets the pace for the rest of the industry. At the time, the public companies were all doing well, though things have certainly changed since then. Among my takeaways, I wrote about how larger […]
When Amedisys Inc. (Nasdaq: AMED) purchased Contessa Health, it touted the acquistion as a future-facing move that would allow the company to care for patients across the continuum. The company’s leaders knew it would be a near-term drag, and some analysts and home health insiders scratched their heads. Still, Amedisys reiterated the opportunity it saw […]
The average age of an Amedisys Inc. (Nasdaq: AMED) patient is about 78. The current age of the oldest baby boomer is about 77, which suggests that a whole new population could be entering its census in the near-term future. On top of that, elective procedures are returning to pre-pandemic levels, representing about 8% of […]
Amedisys Inc. (Nasdaq: AMED) will soon be in a league of its own, at least to a certain extent. There are certainly plenty of independent, home-focused companies still on the publicly traded market. But the Baton Rouge, Louisiana-based provider has seen its direct peers go one way or the other over the years, especially of […]
Amedisys Inc. (Nasdaq: AMED) has been vocal about leaning into the opportunities that offering higher-acuity care in the home will bring. That has also had an influence on the company’s M&A and JV strategies. “Our acquisition of Contessa Health last year created the platform for us to directly offer those high-acuity services,” Kris Novak, vice […]
The pace hasn’t been as aggressive as some expected, but the home health industry has been undergoing a wave of consolidation over the past several years, with the number of freestanding agencies decreasing annually since at least 2015. While consolidation can certainly bring added stresses for existing operators, experts in the mergers-and-acquisitions field note there […]
Amedisys Inc. (Nasdaq: AMED) has entered into an agreement to acquire the home health assets of AssistedCare Home Health and RH Homecare Services, the latter of which conducts business as AssistedCare of the Carolinas. The agreement marks the second acquisitive move that Amedisys has made in the month of February alone, again signaling a jump-start […]
Amedisys Inc. (Nasdaq: AMED) has entered into an agreement to acquire Evolution Health, a Dallas-based provider of home health, hospice and infusion therapy services. The deal could mark a shift in Amedisys’ mindset, one that its executives said was coming. After remaining mostly quiet on the home health front of late – favoring hospice M&A […]
Home-based care providers are short on workers. It’s the largest, most universal issue facing the home care and home health industries right now. And the problem is being worsened by bottom-line headwinds that come with hiring contract workers meant to fill the void. Almost every publicly traded home health company mentioned the drag that contract […]
During an earnings call on Nov. 3, Amedisys Inc. (Nasdaq: AMED) leaders defended the company’s acquisition of hospital-at-home enabler Contessa Health. They also teased “substantial” deals for the company coming down the pike. A week later, Contessa announced that it had partnered with Penn State Health, which has a footprint that spans across 29 counties […]
By continuing to use the site, you agree to the use of cookies. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. For more information, see our cookie policy
